Source: Journal of the American Society for Mass Spectrometry. Conference titles: Conference on Mass Spectrometry and Allied Topics. Unidades: FM, FMRP
Subjects: GLIOMA, NEOPLASIAS
ABNT
ROSA, José César et al. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 set. 2024. , 2013APA
Rosa, J. C., Marie, S. K. N., Oba-Shinjo, S., Oliveira, J. B. de, Otake, A., Chammas, R., et al. (2013). Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. New York: Faculdade de Medicina, Universidade de São Paulo.NLM
Rosa JC, Marie SKN, Oba-Shinjo S, Oliveira JB de, Otake A, Chammas R, Izumi C, Ramão A, Laure HJ, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. 2013 ; 24[citado 2024 set. 10 ]Vancouver
Rosa JC, Marie SKN, Oba-Shinjo S, Oliveira JB de, Otake A, Chammas R, Izumi C, Ramão A, Laure HJ, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. Journal of the American Society for Mass Spectrometry. 2013 ; 24[citado 2024 set. 10 ]